Mads Jellingsø
Mads joined UNION in 2018 and was in 2021 promoted to Chief Commercial Officer. He brings broad market access experience from Novo Nordisk A/S where he was part of building […]
Dr. Günter Ditzinger
Dr. Günter Ditzinger has more than 30 years of pharmaceutical innovation experience spanning early development to product launch at Sanofi and subsequently Novartis. Before joining UNION in 2020, Günter was […]
Eckhard Niemeier
Eckhard Niemeier is a highly experienced deal maker in the life science sector, drawing on almost 20 years of experience in corporate development, corporate strategy and financial analysis and valuation. […]
Dr. Morten Sommer
Morten Sommer is the co-Founder of several biotech companies specialized within the fields of drug development, industrial biotech and microbiome research. Morten is also a Professor and Scientific Director at […]
Dr. Rasmus Toft-Kehler
Rasmus Toft-Kehler is co-founder of UNION. Rasmus has extensive leadership and strategic development experience from founding and building companies in the life science industry, and he is co-founder and board […]
Morten H. Boesen
Morten H. Boesen joined UNION in 2018 as Chief Financial Officer. Prior to UNION, Morten worked with EQT, the largest private equity fund in the Nordics, initially as an investment […]
Dr. Kim Domela Kjøller
Dr. Kim D. Kjøller joined UNION in 2021. He brings more than 20 years of experience from various senior executive positions in the pharmaceutical industry, of which the last 10 […]
